A Wash­ing­ton CMO is dou­bling its man­u­fac­tur­ing ca­pac­i­ty, less than 5 years in­to its ex­is­tence

Just three years in­to its ex­is­tence, Selkirk Phar­ma has start­ed the ex­pan­sion of its 145,000-square-foot fill-fin­ish fa­cil­i­ty in Spokane, WA. The CMO will near­ly dou­ble its ca­pac­i­ty, some­thing it said was crit­i­cal in a June 1 press re­lease.

“Selkirk was found­ed two years pri­or to the on­set of the Covid-19 pan­dem­ic with the in­tent to build a much-need­ed phar­ma­ceu­ti­cal man­u­fac­tur­ing ca­pac­i­ty on US soil,” CEO Patrick Haf­fey said in a state­ment. “See­ing 3 years of work come to­geth­er in the con­struc­tion of this build­ing is an im­por­tant mile­stone for our bio­phar­ma­ceu­ti­cal clients and their pa­tients.”

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER